Mette Eknæs
- Principal engineer
- +47 2278 1717
Fax: +47 22934440
Lothe group, Department of Molecular Oncology.
Publications 2017
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
Mol. Cancer, 16, 116
DOI 10.1186/s12943-017-0691-y
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
Int. J. Cancer, 141 (5), 967-976
DOI 10.1002/ijc.30796
Publications 2014
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
Epigenetics, 9 (3), 428-436
DOI 10.4161/epi.27554
A novel transcript, VNN1-AB, as a biomarker for colorectal cancer
Int. J. Cancer, 135 (9), 2077-2084
DOI 10.1002/ijc.28855
Publications 2013
Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma
PLoS One, 8 (11), e79602
DOI 10.1371/journal.pone.0079602
Publications 2010
Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group
J. Clin. Oncol., 28 (9), 1573-1582
DOI 10.1200/JCO.2009.24.8989
Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
Clin. Cancer Res., 16 (23), 5842-5851
DOI 10.1158/1078-0432.CCR-10-1312
Publications 2008
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis
J. Transl. Med., 6, 13
DOI 10.1186/1479-5876-6-13
Publications 2004
Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients
Mol. Cancer, 3, 6
DOI 10.1186/1476-4598-3-6